A Northwestern Medicine study has uncovered how chronic defects in muscle membrane repair can fuel harmful inflammation. The ...

Researchers at the USF Health Morsani College of Medicine have identified a potential pathway that could protect cardiac ...

The Food and Drug Administration (FDA) has approved the first gene therapy for the treatment of Duchenne muscular dystrophy (DMD) in children from age 4 through 5 years of age. Pediatric patients who ...

Sonothera is developing a new way to deliver genes into cells that, if borne out, could have a big impact on muscular ...

Priority Review granted; PDUFA target action date set for January 21, 2027 -- Submission for Accelerated Approval based on dystrophin as a ...

A new mouse model mimicking the liver symptoms of myotonic dystrophy type 1 -- the most prevalent form of adult-onset muscular dystrophy -- provides insight into why patients develop fatty liver ...

Tributes flooded the internet for Gilbert Gottfried after his family shared on Tuesday via Twitter that he died following “a long illness.” Since then, there has been more awareness around muscular ...

The most commonly diagnosed form of muscular dystrophy, Duchenne is a genetic disease that affects mostly boys and causes progressive muscle weakness over time. Its early physical signs tend to be ...

TOKYO--(BUSINESS WIRE)--Duchenne Muscular Dystrophy (DMD) patients showed signs of disease progress slowing down, after oral consumption of Neu REFIX ß-glucan for 45 days along with routine ...

For decades, researchers studying myotonic dystrophy type 1 (DM1) have focused on the disease's underlying genetic cause: a ...

When Angelina Olivera cried out to God and asked why she had been called to help a family member walk the path of Duchenne muscular dystrophy for a third time, she said she received an answer that ...